Variant report
Variant | esv3357414 |
---|---|
Chromosome Location | chr8:3549344-3553542 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:3 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | POLR2A | chr8:3553527-3553965 | H1-neurons | neurons: | n/a | n/a |
2 | REST | chr8:3553420-3553877 | H1-neurons | neurons: | n/a | n/a |
3 | SUZ12 | chr8:3551293-3551583 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNA5SP251 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs113291996 | chr8:3549357-3549358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs562280576 | chr8:3549362-3549363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs183684295 | chr8:3549363-3549364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547632991 | chr8:3549365-3549366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs187956542 | chr8:3549377-3549378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs191904407 | chr8:3549383-3549384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566364800 | chr8:3549397-3549398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs139392005 | chr8:3549403-3549404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs118148878 | chr8:3549406-3549407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs76904276 | chr8:3549424-3549425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555181430 | chr8:3549434-3549435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs2624071 | chr8:3549438-3549439 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs550031859 | chr8:3549447-3549448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs369967840 | chr8:3549489-3549490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs542325527 | chr8:3549492-3549493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs568403166 | chr8:3549497-3549498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs183717516 | chr8:3549499-3549500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs144117370 | chr8:3549525-3549526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs572529020 | chr8:3549529-3549530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs186683191 | chr8:3549532-3549533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs372603625 | chr8:3549535-3549536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs191495857 | chr8:3549562-3549563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs115898955 | chr8:3549565-3549566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs543494503 | chr8:3549566-3549567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs557392512 | chr8:3549571-3549572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs7837233 | chr8:3549581-3549582 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs146487863 | chr8:3549597-3549598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541187715 | chr8:3549602-3549603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559537191 | chr8:3549619-3549620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs185411633 | chr8:3549622-3549623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs534099408 | chr8:3549656-3549657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs57376617 | chr8:3549667-3549668 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs531326087 | chr8:3549675-3549676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs143719296 | chr8:3549677-3549678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs190658767 | chr8:3549688-3549689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs535755369 | chr8:3549694-3549695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs547577396 | chr8:3549698-3549699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs151056192 | chr8:3549718-3549719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs199588479 | chr8:3549725-3549726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs181715024 | chr8:3549731-3549732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs539291636 | chr8:3549737-3549738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs558225043 | chr8:3549740-3549741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs576509170 | chr8:3549744-3549745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs143769538 | chr8:3549763-3549764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs540960724 | chr8:3549784-3549785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs555352009 | chr8:3549787-3549788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs560714212 | chr8:3549795-3549796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs547700989 | chr8:3550001-3550002 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs566021894 | chr8:3550013-3550014 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs2623599 | chr8:3550014-3550015 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Ovarian cancer | 22355333 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 22014273 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:3549200-3549800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr8:3549200-3549800 | Enhancers | Rectal Mucosa Donor 31 | rectum |
3 | chr8:3550000-3550200 | Active TSS | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr8:3550200-3551800 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr8:3551400-3552400 | Enhancers | Fetal Muscle Leg | muscle |
6 | chr8:3551600-3552400 | Enhancers | Fetal Muscle Trunk | muscle |
7 | chr8:3551800-3552400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |